Caribou Biosciences

AbbVie Terminates Collaboration and License Agreement with Caribou Biosciences
Best Stocks
Tue, 09/26/23 - 10:12 pm
AbbVie
Caribou Biosciences
CRISPR
3 Reasons Why Caribou Biosciences Is a Screaming Buy in July and Beyond
Motley Fool
Fri, 07/28/23 - 10:38 am
Caribou Biosciences
cell therapy
CB-010
relapsed or refractory B cell lymphoma
This 1 Innovation Could Make These 2 Biotechs Soar by 2030
Motley Fool
Sun, 07/23/23 - 12:28 pm
cell therapy
Caribou Biosciences
CRISPR Therapeutics
Caribou Scores Early CAR-T Lymphoma Win, Plans $125M Public Offering
BioSpace
Fri, 07/14/23 - 10:03 am
Caribou Biosciences
CAR-T
CB-010
B-cell non-Hodgkin lymphoma
cell therapy
Pfizer pours $25M investment into Caribou's cell therapies
Fierce Biotech
Thu, 07/6/23 - 10:19 am
Pfizer
Caribou Biosciences
gene editing
CAR-T
Multiple Myeloma
BIO: Caribou tries to 'go where the puck is going' by taking on cell therapy rivals on home ice
Fierce Biotech
Wed, 06/7/23 - 09:40 pm
BIO 2023
Caribou Biosciences
lymphoma
CRISPR
cell therapy
Caribou gets FDA fast track for allogeneic CAR-T
Biopharma Reporter
Tue, 04/11/23 - 10:02 am
Caribou Biosciences
FDA
Multiple Myeloma
CAR-T
CB-011
The hangover: Caribou's allogeneic CAR-T hit by durability doubts as half of patients relapse
Fierce Biotech
Fri, 06/10/22 - 10:55 am
Caribou Biosciences
CRISPR
CAR-T
allogenic CAR-T
EHA
non-Hodgkin's lymphoma
EHA 2022 preview – some good news at last
EP Vantage
Mon, 05/16/22 - 10:14 am
EHA
Caribou Biosciences
CB-010
Gracell
Autolus
Roche
Curocell
ADC Therapeutics
Mustang Bio
Cell therapy, AI drug discovery highlight 2021’s record year in biotech IPOs
MedCity News
Fri, 12/31/21 - 11:04 am
IPOs
cell therapy
artificial intelligence
Sana Biotechnology
Lyell Immunopharma
Caribou Biosciences
Instil Bio
Talaris Therapeutics
Achilles Therapeutics
Biotech listings show signs of a slowdown
EP Vantage
Wed, 10/6/21 - 10:38 am
IPOs
Adagio Therapeutics
Caribou Biosciences
Erasca
DiCE Therapeutics
Icosavax
Caribou raises $304M in one of gene editing's most lucrative IPOs
BioPharma Dive
Sat, 07/24/21 - 06:34 pm
Caribou Biosciences
CRISPR
gene editing
IPOs
The incubator that hatched a Jennifer Doudna CRISPR startup blueprints new 'destination for life science entrepreneurship'
EP Vantage
Tue, 05/11/21 - 11:02 am
Caribou Biosciences
Zymergen
incubators
QB3
Jennifer Doudna
Caribou Biosciences is Armoring Cells to Fight Disease Through CRISPR
BioSpace
Mon, 03/29/21 - 11:07 pm
Caribou Biosciences
CRISPR
Doudna-founded biotech Caribou raises fresh funds to fuel gene editing pipeline
BioPharma Dive
Wed, 03/3/21 - 11:00 am
Caribou Biosciences
Jennifer Doudna
CRISPR
gene editing
After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact
Fierce Biotech
Wed, 02/10/21 - 10:27 am
AbbVie
Editas Medicine
CRISPR
Caribou Biosciences
gene editing
Living the CRISPR dream
Pharmaforum
Thu, 03/28/19 - 09:56 am
Caribou Biosciences
gene editing
CRISPR
At 31, she runs one of the hottest biotech companies in the country
Stat
Wed, 06/22/16 - 07:04 pm
CRISPR
Caribou Biosciences
Novartis moves into genome editing with collaboration deal
Seeking Alpha
Wed, 01/7/15 - 09:26 am
Novartis
genome editing
Intellia Therapeutics
Caribou Biosciences